Price loading...

The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in the United States

Price data last checked 102 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
26 October 2022
Listed Since
10 November 2022

Similar Products You Might Like

The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in India
98% match

The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in India

£515.00 12 Jan 2026
The 2023-2028 Outlook for Hormone Replacement Therapies in the United States
98% match

The 2023-2028 Outlook for Hormone Replacement Therapies in the United States

£520.00 11 Jan 2026
The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics for US Zip Codes
97% match

The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics for US Zip Codes

£490.00 14 Jan 2026
The 2023-2028 Outlook for Testosterone Replacement Therapy for Male Hypogonadism in the United States
97% match

The 2023-2028 Outlook for Testosterone Replacement Therapy for Male Hypogonadism in the United States

£520.00 10 Dec 2025
The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in the United States
97% match

The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in the United States

£520.00 10 Dec 2025
The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in the United States
97% match

The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in the United States

£520.00 21 Jan 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in the United States
97% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in the United States

£520.00 24 Jan 2026
The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in the United States
97% match

The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in the United States

£520.00 05 Feb 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in the United States
97% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in the United States

£520.00 26 Feb 2026
The 2023-2028 Outlook for Gynecologic Oncology in the United States
96% match

The 2023-2028 Outlook for Gynecologic Oncology in the United States

£520.00 01 Feb 2026
The 2023-2028 Outlook for Cancer Supportive Care in the United States
96% match

The 2023-2028 Outlook for Cancer Supportive Care in the United States

£520.00 24 Jan 2026
2023-2028 Outlook for Endometrial Cancer Treatments in US
96% match

2023-2028 Outlook for Endometrial Cancer Treatments in US

£520.00 03 Mar 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in the United States
96% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in the United States

£520.00 22 Jan 2026
The 2023-2028 Outlook for Lymphoma Treatments in the United States
96% match

The 2023-2028 Outlook for Lymphoma Treatments in the United States

£520.00 29 Jan 2026
The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in the United States
96% match

The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in the United States

£520.00 12 Jan 2026
The 2023-2028 Outlook for Prostaglandin Glaucoma Therapeutics in the United States
96% match

The 2023-2028 Outlook for Prostaglandin Glaucoma Therapeutics in the United States

£520.00 07 Feb 2026
The 2023-2028 Outlook for Advanced Therapy Medicinal Products in the United States
96% match

The 2023-2028 Outlook for Advanced Therapy Medicinal Products in the United States

£520.00 14 Jan 2026
The 2023-2028 Outlook for Pruritus Corticosteroid Therapeutics in the United States
96% match

The 2023-2028 Outlook for Pruritus Corticosteroid Therapeutics in the United States

£520.00 30 Jan 2026
The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in the United States
96% match

The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in the United States

£520.00 22 Jan 2026
The 2023-2028 Outlook for Bile Duct Cancer (Cholangiocarcinoma) Treatments in the United States
96% match

The 2023-2028 Outlook for Bile Duct Cancer (Cholangiocarcinoma) Treatments in the United States

£520.00 10 Jan 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma in the United States
96% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma in the United States

£520.00 12 Jan 2026
The 2023-2028 Outlook for Gonorrhea Therapeutics in the United States
96% match

The 2023-2028 Outlook for Gonorrhea Therapeutics in the United States

£520.00 05 Feb 2026
The 2023-2028 Outlook for Basal Cell Carcinoma Treatments in the United States
96% match

The 2023-2028 Outlook for Basal Cell Carcinoma Treatments in the United States

£520.00 12 Jan 2026
The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in the United States
96% match

The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in the United States

£520.00 03 Feb 2026